Read on Twitter
Today is #WorldCancerDay 
- a day to reflect on the global #cancer burden and millions of lives lost each year. Our Centre investigators are proud to be part of the war on cancer and today we would like to share with you some of our history and achievements so follow this thread!
- a day to reflect on the global #cancer burden and millions of lives lost each year. Our Centre investigators are proud to be part of the war on cancer and today we would like to share with you some of our history and achievements so follow this thread!
We started as a small portacabin lab on the Western General Hospital campus in #Edinburgh with main focus on the development of more successful drug therapies for all forms of cancer and looking for new ways of reducing the side-effects of anti-cancer drugs.
Our researchers were responsible for the very first clinical trial of a 5-HT3 receptor antagonist, heralding in the dramatic changes in emesis control that subsequently followed the development of that class of compounds.
https://en.wikipedia.org/wiki/5-HT3_antagonist
https://en.wikipedia.org/wiki/5-HT3_antagonist
Over the years, from a portable cabin it was in early 1980s, our Centre has developed into a world leading #Cancer #Research Institution it is today. This was only possible because of dedication of our staff, patients and supporters. So Big Thank You to all these people!
Our goals remain the same: to expand knowledge of cancer and explore new therapeutic opportunities. We are active in basic (non-clinical), translational and clinical #cancer #research.
Our clinical/translational emphasis is largely in colorectal cancer, women’s cancers (breast, ovarian and endometrial), and in brain cancer, but many other areas are also actively pursued.
Some of notable achievements from our Centre’s researchers and clinicians over the years include.
Helping introduce new breast cancer therapy globally: https://www.ed.ac.uk/files/atoms/files/lapatinibareknewfinished_final.pdf
Helping introduce new breast cancer therapy globally: https://www.ed.ac.uk/files/atoms/files/lapatinibareknewfinished_final.pdf
… and
Evidence-based identification and cost-effective treatment of depression in cancer patients: https://www.ed.ac.uk/files/atoms/files/depressionandcancer_final.pdf
Evidence-based identification and cost-effective treatment of depression in cancer patients: https://www.ed.ac.uk/files/atoms/files/depressionandcancer_final.pdf
Some of of our more recent contributions to the war on #cancer include UK lead of the pivotal SOLO-1 clinical trial that helped to approve olaparib as maintenance treatment for patients with advanced ovarian cancer: https://www.ed.ac.uk/cancer-centre/news-and-events/news-2019/olaparib-approve-scotland-ovarian-cancer-treatment
New chemotherapy approach that offers breast cancer patients a better quality of life: https://www.ed.ac.uk/cancer-centre/news-and-events/latest-news/new-chemotherapy-approach-offers-breast-cancer
Development of the Edinburgh Pain Assessment and management Tool (EPAT) that can help ease cancer patients' pain: https://www.ed.ac.uk/cancer-centre/news-and-events/news-2018/cancer-patients-pain-eased-simple-bedside-chart
